Learn More
Medchemexpress LLC Migoprotafib (GDC-1971) | 2377352-49-1 | 98.8% | C25H26N8O | 50 MG

Supplier: Medchemexpress LLC HY14490350MG
Migoprotafib (GDC-1971) is a SHP2 inhibitor that inhibits the MAPK/ERK signaling pathway and exhibits antitumor activity.
- Inhibits the proliferation of RIT1 cells by blocking the MAPK and ERK signaling pathway in vitro.
- Demonstrates antitumor efficacy in RIT1 xenograft mouse models in vivo.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.